Minoo, Japan

Ying-She Cui

This inventor holds 1 USPTO granted patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying-She Cui. Retrieved from https://idiyas.com/inventor/ying-she-cui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying-She Cui: Innovator in Cysteine Inhibition

Introduction

Ying-She Cui is a notable inventor based in Minoo, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cysteine inhibitors. His work is characterized by a commitment to innovation and a focus on improving therapeutic options.

Latest Patents

Ying-She Cui holds a patent for "Piperazine derivatives and use as cysteine inhibitors." This patent represents a crucial advancement in the search for effective treatments targeting cysteine-related pathways.

Career Highlights

Cui is currently employed at Senju Pharmaceutical Co., Ltd., where he continues to engage in groundbreaking research. His expertise in medicinal chemistry has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Ying-She Cui has collaborated with esteemed colleagues, including Jun Inoue and Yuka Yoshida. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries.

Conclusion

Ying-She Cui's contributions to the field of cysteine inhibition exemplify the impact of dedicated research and innovation in pharmaceuticals. His work continues to inspire advancements in therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…